April 17, 2024



Experimental blood cancer therapy already available in the US has 90 PERCENT success rate in new trial — but hardly anyone can access it

Daily Mail News UK – Health

An experimental cancer treatment has a 90 percent success rate in patients with multiple myeloma, one of the most common blood cancers in the world. 

Researchers at Hadassah-University Medical Center in Jerusalem, Israel, used a treatment called Chimeric Antigen Receptor T-Cell Therapy, or CAR-T, which boosts the patient’s own immune system to destroy cancer cells. 

Of the 74 patients with multiple myeloma who were given the drug, 90 percent went into complete remission, meaning they had no signs of cancer remaining.

Read more…